Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (481-490 of 6,826) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|November 4, 2020
Myosin inhibitor flexes, myosin activator flopsAsher Mullard
Nature Reviews. Drug Discovery|October 31, 2017
Preclinical antibiotic pipeline gets a pick-me-upAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2019
FDA approves oral version of diabetes biologicAsher Mullard
Journal of Experimental Psychology. General|January 26, 2018
When reality is out of focus: Can people tell whether their beliefs and judgments are correct or wrong?Asher Koriat
Nature Reviews. Drug Discovery|February 2, 2018
2017 FDA drug approvalsAsher Mullard
Nature Reviews. Drug Discovery|February 2, 2018
Top product sales forecasts for 2018Asher Mullard
Nature Reviews. Drug Discovery|May 17, 2022
DNA damage response drugs for cancer yield continued synthetic lethality learningsAsher Mullard
Nature Reviews. Drug Discovery|May 17, 2022
Do fourth-generation EGFR inhibitors showcase the future of kinase inhibitors?Asher Mullard
Nature Reviews. Drug Discovery|June 30, 2021
First clinical test of an in vivo CRISPR candidate shows deep protein knockout potentialAsher Mullard
Nature|July 1, 2021
Controversial Alzheimer's drug approval could affect other diseasesAsher Mullard
Pageof 683

Showing results (481-490 of 6,826) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|November 4, 2020
Myosin inhibitor flexes, myosin activator flopsAsher Mullard
Nature Reviews. Drug Discovery|October 31, 2017
Preclinical antibiotic pipeline gets a pick-me-upAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2019
FDA approves oral version of diabetes biologicAsher Mullard
Journal of Experimental Psychology. General|January 26, 2018
When reality is out of focus: Can people tell whether their beliefs and judgments are correct or wrong?Asher Koriat
Nature Reviews. Drug Discovery|February 2, 2018
2017 FDA drug approvalsAsher Mullard
Nature Reviews. Drug Discovery|February 2, 2018
Top product sales forecasts for 2018Asher Mullard
Nature Reviews. Drug Discovery|May 17, 2022
DNA damage response drugs for cancer yield continued synthetic lethality learningsAsher Mullard
Nature Reviews. Drug Discovery|May 17, 2022
Do fourth-generation EGFR inhibitors showcase the future of kinase inhibitors?Asher Mullard
Nature Reviews. Drug Discovery|June 30, 2021
First clinical test of an in vivo CRISPR candidate shows deep protein knockout potentialAsher Mullard
Nature|July 1, 2021
Controversial Alzheimer's drug approval could affect other diseasesAsher Mullard
Pageof 683